Orally disintegrating antipsychotics may promote compliance and adherence in patients with schizophrenia.
Tornatore
Frank L
FL
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001682:Biological Availability; D018849:Controlled Clinical Trials as Topic / Q000706:statistics & numerical data; D003692:Delayed-Action Preparations; D006801:Humans; D007273:Injections, Intramuscular; D010349:Patient Compliance; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D012565:Schizophrenic Psychology; D013607:Tablets
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D013607:Tablets